“…Cumulative evidence indicates that, among their diverse properties, interferons may have a regulatory influence on several immune functions: suppression of lymphocyte proliferation in response to mitogens and alloantigens (LindahlMagnusson et al, 1972a); inhibition in vivo and in vitro of antibody formation to T-cell-dependent and independent antigens (Braun & Levy, 1972;Gisler et al, 1974;Johnson et al, 1975;Sonnenfeld et al, 1977) and enhancement of specific cell-mediated cytotoxicity evoked by tumour-and allo-antigens (Lindahl et al, 1972b;Heron et al, 1976;Zarling et al, 1978). Interferon may also stimulate other effector-cell-mediated mechanisms such as phagocytosis (Huang et al, 1971;Donahoe & Huang, 1976) and nonspecific cytotoxicity (Schultz et al, 1977;Einhorn et al, 1978;Djeu et al, 1979;Senik et al, 1979), act directly on various cell types to inhibit their growth in vitro (Stewart et al, 1976;Balkwill et al, 1978) and modulate the expression of cell surface antigens on lymphocytes and tumour cells (Vignaux & Gresser, 1977).…”